Archive
New optically pumped magnetometers (OPM) coming to Oxford
Post published: 16 May, 2024
The Oxford Centre for Human Brain Activity, led by Prof. Mark Woolrich, has been granted a cutting-edge piece of neuroimaging equipment – the Optically Pumped Magnetometers (OPMs).
AI to help personalise treatment for depression as part of major trial
Post published: 13 May, 2024
People with depression are being invited to be part of a clinical trial testing a new evidence-based AI treatment tool to personalise antidepressant treatment.
Professor Mina Fazel appointed Chair of Child and Adolescent Psychiatry
Post published: 18 Apr, 2024
She will lead the Child and Adolescent Psychiatry research group, aiming to better understand how to prevent mental health difficulties in children and young people and how best to support them and their families.
Trial including Oxford will test if drug can reduce depression following brain injury
Post published: 5 Apr, 2024
Up to 50 per cent of people who suffer a traumatic brain injury (TBI) go on to develop some form of depression in the 10 years following the injury.
Blood tests for diagnosing dementia a step closer
Post published: 4 Apr, 2024
The University of Oxford and Oxford Health Clinical Research Facility is part of country-wide trials to identify accurate and quick blood tests that can diagnose dementia.
What is Patient and Public Involvement?
Post published: 30 Mar, 2024
Everyone benefits from research. Research provides evidence about what works best. Patients, carers, people who use social care services and health & social care professionals all use this evidence to make decisions about treatments and care.
Reflections on conducting inclusive, participatory research in NHS settings
Post published: 27 Mar, 2024
Dr Roisin Mooney, Project Manager and Postdoctoral Researchers in the CHiMES Collaborative and Co-Principal Investigator of the Co-Pact study, outlines her thoughts on important considerations for inclusive research, based on her experience.
Recruitment for Alzheimer’s Disease study now open at Oxford Health Clinical Research Facility (OH CRF)
Post published: 22 Feb, 2024
Alzheimer’s Disease is a type of dementia in which abnormal proteins, called beta-amyloid and tau, accumulate in the brain and damage nerve cells. People with Alzheimer’s Disease often have trouble thinking, speaking, remembering things, and performing their daily activities. This condition is common in older people and gets worse over time.
New online tool that empowers parents to treat child anxiety could expand access to child mental health services
Post published: 7 Feb, 2024
New research from the University of Oxford has revealed that an online programme that empowers parents to apply Cognitive Behavioural Therapy (CBT) principles in their child’s day to day lives is just as effective as traditional talking therapies for child anxiety problems.
Call for more research investment for serious mental illness treatments
Post published: 7 Dec, 2023
More focused research on medication for serious mental illness is needed in the UK according to a leading Oxford Professor.